Aurora Biosciences

Aurora Biosciences was a biotechnology company founded in the early 1990s in San Diego that specialized in high-throughput screening and assay development for pharmaceutical discovery. The firm operated at the intersection of molecular biology, robotics, and fluorescence technologies, serving clients in drug discovery pipelines and collaborating with academic institutions, biotech companies, and government laboratories.

History

Aurora Biosciences was founded amid a wave of biotechnology entrepreneurship that included firms such as Genentech, Amgen, Genzyme, Vertex Pharmaceuticals, Biogen, Regeneron Pharmaceuticals, Celgene, Gilead Sciences, MedImmune, Biomarin Pharmaceutical, Alnylam Pharmaceuticals, Illumina, Agilent Technologies, PerkinElmer, Applied Biosystems, Thermo Fisher Scientific, Merck & Co., Pfizer, GlaxoSmithKline, Novartis, Roche, Sanofi, AstraZeneca, Eli Lilly and Company, AbbVie, Bristol-Myers Squibb, Takeda Pharmaceutical Company, Johnson & Johnson, Bayer, Baxter International, Amylin Pharmaceuticals, Scios, Dendreon, Human Genome Project, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Salk Institute, Scripps Research, University of California, San Diego, Stanford University, Massachusetts Institute of Technology, Harvard University, Yale University, Columbia University, University of Cambridge, University of Oxford, Max Planck Society, European Molecular Biology Laboratory, National Institutes of Health, National Science Foundation, Defense Advanced Research Projects Agency, U.S. Department of Energy, Sandia National Laboratories, Los Alamos National Laboratory, Lawrence Berkeley National Laboratory, Argonne National Laboratory, Oak Ridge National Laboratory as part of a network shaping early biotech-industrial partnerships. Founders and early executives had previous ties to academic labs and companies like Genentech and Scripps Research, positioning the company to work closely with investors and collaborators including Sequoia Capital, Kleiner Perkins, OrbiMed Advisors, SV Health Investors, Goldman Sachs, Morgan Stanley, JP Morgan Chase, Bank of America, Wells Fargo, Citigroup, Deutsche Bank, UBS, Credit Suisse, Barclays, Rothschild & Co., Perella Weinberg Partners, Lehman Brothers during fundraising and M&A discussions.

Technology and Products

Aurora focused on assay platforms that combined fluorescence detection, plate readers, and robotic liquid handling comparable to equipment from PerkinElmer, Tecan, Beckman Coulter, Hamilton Company, Agilent Technologies, Thermo Fisher Scientific, BioTek Instruments, Molecular Devices, BMG Labtech, Horiba Scientific, Shimadzu, Hitachi High-Tech Corporation, Eppendorf, Sartorius, Corning Incorporated, Greiner Bio-One International, Sigma-Aldrich, BD (Becton Dickinson), Corning Life Sciences. Their products leveraged fluorescent proteins and small-molecule fluorophores like those developed at Howard Hughes Medical Institute, with assay formats used by teams at institutions including Scripps Research, University of California, San Diego, Massachusetts General Hospital, Dana–Farber Cancer Institute, Johns Hopkins University, Mayo Clinic, Cleveland Clinic', Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center.

Research Contributions

Aurora contributed to screening technologies influencing research in ion channels, G protein-coupled receptors, and kinase signaling pathways central to work at National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, European Medicines Agency, World Health Organization, Bill & Melinda Gates Foundation, Wellcome Trust, Howard Hughes Medical Institute, Max Planck Society, European Molecular Biology Laboratory, Cold Spring Harbor Laboratory. Their assay development supported drug discovery programs similar to those that produced therapeutics at Pfizer, Merck & Co., Novartis, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Roche, Sanofi, AbbVie, Bristol-Myers Squibb. Collaborations and citations placed their technologies in the same discourse as breakthroughs from James Watson, Francis Crick, Craig Venter, Jennifer Doudna, Emmanuelle Charpentier, Katalin Karikó, Drew Weissman, Har Gobind Khorana, Marshall Nirenberg, Sidney Brenner, Sydney Brenner, John Sulston, Harvard Medical School, Yale School of Medicine.

Business and Corporate Developments

Aurora underwent corporate transitions and was acquired by larger entities during consolidation waves that also affected companies like Q-State Biosciences, Sangamo Therapeutics, Incyte Corporation, Alkermes, Shire plc, Actelion, Alexion Pharmaceuticals, Endo International, Ipsen, Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries, Mylan (now Viatris), Horizon Therapeutics, Oklahoma Medical Research Foundation, BioTime, Agendia. Its acquisition and integration reflected patterns seen in mergers involving Pfizer, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Sanofi, Takeda Pharmaceutical Company and private equity deals led by firms like Warburg Pincus, The Carlyle Group, Kohlberg Kravis Roberts, Blackstone Group, TPG Capital, Bain Capital, Apollo Global Management.

Intellectual Property and Collaborations

Aurora maintained patents and collaborations that intersected with intellectual property landscapes navigated by entities such as Genentech, Amgen, Biogen, Gilead Sciences, Regeneron Pharmaceuticals, Vertex Pharmaceuticals, Illumina, Oxford Nanopore Technologies, CRISPR Therapeutics, Intellia Therapeutics, Editas Medicine, Sangamo Therapeutics, Bluebird Bio, Moderna, BioNTech, Novavax, Vaccinex, AstraZeneca, Roche Diagnostics, Siemens Healthineers, Qiagen, Agilent Technologies, Thermo Fisher Scientific, PerkinElmer, Corning Incorporated, Sigma-Aldrich. Collaborations extended to academic consortia at University of California, San Diego, Salk Institute, Scripps Research, Cold Spring Harbor Laboratory, Harvard University, Stanford University, Massachusetts Institute of Technology and prompted licensing discussions similar to those involving the Human Genome Project and technology transfers from national laboratories including Lawrence Berkeley National Laboratory and Los Alamos National Laboratory.

Category:Biotechnology companies